Distinguished guests, colleagues, and friends from around the world,
On behalf of the Taiwan Society for Immunotherapy of Cancer (TSITC) and the Taiwan Oncology Society (TOS), it is my great honor and pleasure to welcome you all to WIC-APAC 2026, here in Taiwan.
This marks the very first time that the WIC-APAC regional meeting is being hosted in Taiwan, and we are thrilled to bring together leading experts, clinicians, researchers, and young investigators from across Asia and beyond to explore the latest advancements in cancer immunotherapy.
Jointly organized by TSITC and TOS, this meeting integrates international plenary sessions, a robust young physician training program, dedicated forums for nurses and pharmacists, and the annual academic sessions of both societies. It is a testament to our commitment to advancing Immune-Oncology through collaboration, innovation, and education.
We are especially grateful for the guidance and support from the World Immunotherapy Council (WIC), the Society for Immunotherapy of Cancer (SITC), and our partners throughout the Asia-Pacific region. Your participation enriches this meeting and strengthens our shared vision for the future of immuno-oncology.
We hope that this event will spark meaningful dialogue, cross-disciplinary collaboration, and new friendships. And while you’re here, we warmly invite you to experience the vibrant culture, hospitality, and beauty of Taiwan.
Thank you once again for joining us. I wish you all a successful and inspiring conference.
Dr. John Wen-Cheng Chang Conference Chair, WIC APAC 2026 | 
Dr. Peter Chiao-En Wu President, Taiwan Society for Immunotherapy of Cancer (TSITC) | 
Dr. Jen-Shi Chen President, Taiwan Oncology Society (TOS) |